Technology - Enzymatic Capsulotomy for Shoulder Adhesive Capsulitis

Enzymatic Capsulotomy for Shoulder Adhesive Capsulitis

A minimally invasive collagenase injection method for treating frozen shoulder that is cost-effective

Background:

Adhesive capsulitis of the shoulder, more commonly known as frozen shoulder, results in painful limitation of shoulder motion. It can arise idiopathically or after trauma. The current standard of care is a long course of painful physical therapy to restore shoulder motion. Failing that, patients? often undergo surgical procedures, such as manipulation under general anesthesia, arthroscopy, or even open shoulder surgery.

Technology Overview:

Patients suffering from frozen shoulder may be able to avoid a long course of painful physical therapy, manipulation under general anesthesia, arthroscopy or open shoulder surgery. Instead, researchers from Stony Brook University have invented a less invasive and more cost-effective collagenase injection, or short series of collagenase injections, which may provide relief from this painful and debilitating condition in a timelier manner.
Source: Jesper Aggergaard, unsplash.com/photos/CEM52sAHR80, Unsplash Licence

Advantages:

Less invasive - More cost-effective - Quicker relief

Applications:

Treatment of frozen shoulder

Intellectual Property Summary:

Patented

Stage of Development:

Undergoing FDA approval. PCT Publication No. US 2015-0174216.

Licensing Status:

Exclusive License - All Fields.

Licensing Potential:

Licensing

Additional Information:

Patent Information: